CSI Market
Sign In | Register

Redhill Biopharma Ltd (RDHL) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access RDHL Annual Cash Flow →
The cash flow figures below highlight longer-term patterns in how Redhill Biopharma Ltd manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		0 0 0 (Dec 31 2024)
Operating Activities
Income-0.43
Depreciation & amortization0.38
Amortization of Other Assets0.03
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Adjustments For Sharebased Payments-
Adjustments For Interest Expense-
Gains Losses On Financial Assets At Fair Value Through Profit Or Loss-
Adjustments For Revaluation Of Bank Deposits-
Adjustments To Reconcile Profit Loss Other Than Changes In Working Capital-
Adjustments For Decrease Increase In Inventories-
Adjustments For Increase Decrease In Trade Account Payable-
Adjustments For Decrease Increase In Accrued Expenses-
Adjustments For Increase Decrease In Allowance For Deductions From Revenue-
Increase Decrease In Working Capital-
Income taxes0.00
Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method0.03
Accounts Receivable0.00
Adjustments For Decrease IncreaseIn Trade Account Receivable2.26
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-1.84
Discontinued operations0.00
Net Cash flow from Operating Activities-9.65
Investing Activities
Capital Expenditures-0.01
Sale of Capital Items0.00
Proceeds From Sales Or Maturity Of Financial Instruments Classified As Investing Activities0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Change In Investment In Current Bank Deposits Classed As Investing Activities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Other Cash Payments To Acquire InterestsIn Joint Ventures Classified As Investing Activities-0.30
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net2.00
Discontinued operations0.00
Net Cash Flow from Investing Activities1.69
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net7.32
Repayment Of Payable In Respect Of Intangible Asset Purchase-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities7.32
Effect of exchange rate on cash flow-0.64
Discontinued operations0.00
Free Cash Flow-9.66
Total Cash Flow4.62
4 historic quarters locked

Sign in to unlock the full Redhill Biopharma Ltd cash flow history.

Sign In Create Free Account

About Redhill Biopharma Ltd Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-049055

Figures are derived from filed reports and may be restated. Historical data is subject to revision.